ARTV · Categories · Downgrades
ARTV - Analyst downgrades
Artiva Biotherapeutics Inc. (ARTV) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for ARTV
- Artiva Biotherapeutics downgraded by Jefferies with a new price targetJefferies downgraded Artiva Biotherapeutics from Buy to Hold and set a new price target of $4.00
- Artiva Biotherapeutics downgraded by NeedhamNeedham downgraded Artiva Biotherapeutics from Buy to Hold
- Artiva Biotherapeutics downgraded by Wedbush with a new price targetWedbush downgraded Artiva Biotherapeutics from Outperform to Neutral and set a new price target of $4.00